Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martina Korfei
Comparison of the Antifibrotic Effects of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-drug Pirfenidone in Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
Related publications
Idiopathic Pulmonary Fibrosis (IPF) ― Common Practice in Poland Before the “Antifibrotic Drugs Era”
Advances in Respiratory Medicine
Pulmonary
Respiratory Medicine
The Effect of Food on the Bioavailability of Panobinostat, an Orally Active Pan-Histone Deacetylase Inhibitor, in Patients With Advanced Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis
Internal Medicine
Internal Medicine
Medicine
Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
PLoS ONE
Multidisciplinary
Idiopathic Pulmonary Fibrosis and Pirfenidone
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
M27 Effect of Pirfenidone on Breathlessness as Measured by the Ucsd-Sobq Score in Patients With Idiopathic Pulmonary Fibrosis (Ipf) With Moderate Lung Function Impairment
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
P196 Healthcare Utilisation by Patients With Idiopathic Pulmonary Fibrosis; Observations From the UK Pirfenidone Named Patient Programme
Thorax
Pulmonary
Respiratory Medicine
